Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Rustenbeck

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|March 18, 2016
[Risk and benefit of sulfonylureas--their role in view of new treatment options for type 2 diabetes]Ingo Rustenbeck
Biochemical Pharmacology|July 3, 2002
Desensitization of insulin secretionIngo Rustenbeck
Medizinische Monatsschrift Fur Pharmazeuten|May 9, 2007
[Unconventional antidiabetic agents]Ingo Rustenbeck
Medizinische Monatsschrift Fur Pharmazeuten|May 19, 2009
[Fixed drug combinations--the pros and the cons]Ingo Rustenbeck
European Journal of Pharmacology|February 24, 2009
Triggering and amplification of insulin secretion by dimethyl alpha-ketoglutarate, a membrane permeable alpha-ketoglutarate analogueMichael Willenborg, Uwe Panten, Ingo Rustenbeck
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 29, 2013
Effect of fluoroquinolones on mitochondrial function in pancreatic beta cellsHany Ghaly, Anne Jörns, Ingo Rustenbeck
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
Determination of beta-cell function: insulin secretion of isolated isletsMichael Willenborg, Kirstin Schumacher, Ingo Rustenbeck
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 10, 2022
Regulation of insulin secretion in mouse islets: metabolic amplification by alpha-ketoisocaproate coincides with rapid and sustained increase in acetyl-CoA contentUwe Panten, Dennis Brüning, Ingo Rustenbeck
Diabetes|November 25, 2004
Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compoundsClaudia Bleck, Antje Wienbergen, Ingo Rustenbeck
Molecular and Cellular Endocrinology|December 7, 2017
The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca<sup>2+</sup> channels and insulin secretionNele Seemann, Andrea Welling, Ingo Rustenbeck
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Medizinische Monatsschrift Fur Pharmazeuten|March 18, 2016
[Risk and benefit of sulfonylureas--their role in view of new treatment options for type 2 diabetes]Ingo Rustenbeck
Biochemical Pharmacology|July 3, 2002
Desensitization of insulin secretionIngo Rustenbeck
Medizinische Monatsschrift Fur Pharmazeuten|May 9, 2007
[Unconventional antidiabetic agents]Ingo Rustenbeck
Medizinische Monatsschrift Fur Pharmazeuten|May 19, 2009
[Fixed drug combinations--the pros and the cons]Ingo Rustenbeck
European Journal of Pharmacology|February 24, 2009
Triggering and amplification of insulin secretion by dimethyl alpha-ketoglutarate, a membrane permeable alpha-ketoglutarate analogueMichael Willenborg, Uwe Panten, Ingo Rustenbeck
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 29, 2013
Effect of fluoroquinolones on mitochondrial function in pancreatic beta cellsHany Ghaly, Anne Jörns, Ingo Rustenbeck
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2012
Determination of beta-cell function: insulin secretion of isolated isletsMichael Willenborg, Kirstin Schumacher, Ingo Rustenbeck
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 10, 2022
Regulation of insulin secretion in mouse islets: metabolic amplification by alpha-ketoisocaproate coincides with rapid and sustained increase in acetyl-CoA contentUwe Panten, Dennis Brüning, Ingo Rustenbeck
Diabetes|November 25, 2004
Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compoundsClaudia Bleck, Antje Wienbergen, Ingo Rustenbeck
Molecular and Cellular Endocrinology|December 7, 2017
The inhibitor of connexin Cx36 channels, mefloquine, inhibits voltage-dependent Ca<sup>2+</sup> channels and insulin secretionNele Seemann, Andrea Welling, Ingo Rustenbeck
Pageof 5